INNOCARE - Announcement on Convening the 2026 Semi-annual Results Briefing Meeting
InnoCare Pharma Limited
Nuocheng Jianhua Pharmaceutical Co., Ltd.
(Incorporated in the Cayman Islands with limited liability)
(Stock code: 9969)
Overseas regulatory announcement
This announcement is made by InnoCare Pharmaceuticals Limited (the "Company") in accordance with Rule 13.10B of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.
This is to set forth the "Announcement on Convening the 2026 Semi-annual Results Briefing Meeting" published by the Company on the website of the Shanghai Stock Exchange.
By order of the board of directors
Nuocheng Jianhua Pharmaceutical Co., Ltd.
Chairman and Executive Director
Dr. Cui Jisong
Hong Kong, August 17, 2026
As of the date of this announcement, the board of directors includes Dr. Cui Jisong, the chairman and executive director; Dr. Zhao Renbin, the executive director; Dr. Shi Yigong and Mr. Xie Ronggang, the non-executive directors; and Ms. Hu Lan, Dr. Dong Dandan and Professor Guan Kunliang, the independent non-executive directors.
A-share code: 688428 A-share abbreviation: Nuocheng Jianhua Announcement number: 2026-038 Hong Kong stock code: 09969 Hong Kong stock abbreviation: Nuocheng Jianhua
Nuocheng Jianhua Pharmaceutical Co., Ltd.
Announcement on the convening of the semi-annual performance briefing meeting
2026
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents in accordance with the law.
Important content reminder:
Meeting time: August 25, 2026 (Tuesday) 11:00-12:00 am
Meeting location: Shanghai Stock Exchange Roadshow Center (Website: http://roadshow.sseinfo.com/)
Meeting method: Shanghai Securities Roadshow Center online interaction
Investors can log in to the homepage of the SSE Roadshow Center website before 16:00 on August 18, 2026 (Tuesday) to August 24 (Monday) and click on the "Pre-Solicitation for Questions" column or ask questions through the company's email address [email protected]. The company will answer questions of common concern to investors at the briefing.
Innocent Jianhua Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") will release the company's 2026 semi-annual report on August 25, 2026. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's 2026 semi-annual operating results and financial status, the company plans to hold a 2026 semi-annual performance briefing on August 25, 2026 (Tuesday) from 11:00 to 12:00 am to communicate on issues of concern to investors.
- Type of briefing session
This investor briefing will be held in an interactive online format. The company will interact and communicate with investors on the specific operating results and financial indicators for the first half of 2026, and answer questions of common concern to investors to the extent permitted by information disclosure.
- Time and place of the briefing meeting
(1) Meeting time: 11:00-12:00 am on August 25, 2026 (Tuesday)
(2) Meeting location: Shanghai Stock Exchange Roadshow Center (Website: http://roadshow.sseinfo.com/)
(3) Meeting method: Shanghai Securities Roadshow Center online interaction
- Participants
Chairman of the Board and Chief Executive Officer: Dr. Jisong Cui
Independent non-executive director: Ms. Hu Lan
Chief Financial Officer: Mr. Fu Xin
Domestic representative for information disclosure: Ms. Yuan Bei
(Participants may make adjustments if there are special circumstances)
- How investors participate
(1) Investors can log in to the SSE Roadshow Center (https://roadshow.sseinfo.com/) via the Internet from 11:00-12:00 a.m. on August 25, 2026 (Tuesday) to participate in this performance briefing online. The company will answer investors' questions in a timely manner.
(2) Investors can log on to the homepage of the SSE Roadshow Center website before 16:00 on August 18, 2026 (Tuesday) to August 24 (Monday), click on the "Question Pre-Collection" column (https://roadshow.sseinfo.com/preCallQa), select this event according to the event time, or ask questions to the company through the company's email [email protected]. The company will answer questions of common concern to investors at the briefing meeting.
- Contact persons and consultation methods
Contact person: Domestic Securities Affairs Department
Tel: 010-66609913
Email: [email protected]
- Other matters
After the investor briefing is held, investors can check the status and main content of the investor briefing through the SSE Roadshow Center (https://roadshow.sseinfo.com/).
Announcement is hereby made.
Board of Directors of InnoCheng Jianhua Pharmaceutical Co., Ltd.
August 18, 2026